ELMD übertreffen die 18 der letzten 28Schätzungen.
64%
Nächster Bericht
Datum des nächsten Berichts
09. Feb. 2026
Estimate forQ2 26(Revenue/ EPS)
$18.90M
/
$0.27
Implizierte Änderung vonQ1 26(Revenue/ EPS)
+11.89%
/
+8.00%
Implizierte Änderung vonQ2 25(Revenue/ EPS)
+16.24%
/
+22.73%
Electromed, Inc. earnings per share and revenue
On 12. Nov. 2025, ELMD reported earnings of 0.25 USD per share (EPS) for Q1 26, beating the estimate of 0.20 USD, resulting in a 19.56% surprise. Revenue reached 16.89 million, compared to an expected 17.34 million, with a -2.61% difference. The market reacted with a +3.82% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 6 analysts forecast an EPS of 0.27 USD, with revenue projected to reach 18.90 million USD, implying an increase of 8.00% EPS, and increase of 11.89% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
AngioDynamics, Inc.
Report Date
06. Jan. 2026 For Q2 26
Estimate
-$0.10
Aktuell
$0.00
Überraschung
+100.00%
FAQ
What were Electromed, Inc.'s earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Electromed, Inc. reported EPS of $0.25, beating estimates by 19.56%, and revenue of $16.89M, -2.61% below expectations.
How did the market react to Electromed, Inc.'s Q1 2026 earnings?
The stock price moved up 3.82%, changed from $25.38 before the earnings release to $26.35 the day after.
When is Electromed, Inc. expected to report next?
The next earning report is scheduled for 09. Feb. 2026.
What are the forecasts for Electromed, Inc.'s next earnings report?
Based on 6
analysts, Electromed, Inc. is expected to report EPS of $0.27 and revenue of $18.90M for Q2 2026.